viivhealthcare.com.au

positivelivingmagazine.com.au

Discover world-first app for PLHIV | Positive Living Magazine

http://www.positivelivingmagazine.com.au/content/discover-world-first-app-plhiv

Skip to main content. Discover world-first app for PLHIV. Discover world-first app for PLHIV. The world’s first health and wellbeing app for people with HIV MyLife has been launched in Australia. MyLife has been created by. In consulation with people with HIV and in partnership with the National Association of People with HIV Australia. ViiV Healthcare provided the funding and led the expertise for the app development, while through its members NAPWHA played a central role at key stages of its creation.

viivhealthcare.com

Inside ViiV Healthcare | ViiV Healthcare

https://www.viivhealthcare.com/inside-viiv-healthcare.aspx

Positive Partnerships initiative launches in Estonia. Read how ViiV Healthcare's Positive Partnerships programme in Estonia is supporting innovative digital health solutions in HIV. Young Britons break down HIV stigma and isolation to be the #GenEndIt. Read what our Global Medical Lead for Paediatrics Dr Katy Hayward thinks about the urgent need to support young people to tackle HIV stigma and fight the epidemic in the UK and around the world. Addressing HIV in Adolescents.

positivelivingmagazine.com.au

HIV care at your fingertips | Positive Living Magazine

http://www.positivelivingmagazine.com.au/content/hiv-care-your-fingertips

Skip to main content. HIV care at your fingertips. HIV care at your fingertips. While scientific advancements continue to offer hope for a cure for HIV, technology has delivered positive people with the tools to ensure that we can live well in the present. This week saw the launch of the world’s first health and wellness app for people with HIV. MyLife . It's free and can be downloaded onto an android or Apple device. Developed by ViiV Healthcare. Every HIV-positive person can now take control of their p...

viivhealthcare.com

What we do | ViiV Healthcare

https://www.viivhealthcare.com/what-we-do.aspx

We research and develop new HIV medicines. We improve access to our medicines. We partner with the HIV community. We collaborate to innovate. We research and develop new HIV medicines. We are focused on finding new medicines to improve outcomes for people living with HIV and understanding how best to prevent and treat the disease. We improve access to our medicines. We are committed to playing our part in increasing access to HIV treatment by taking an innovative, responsible and sustainable approach.

viivhealthcare.com

Dolutegravir Expanded Access Program | ViiV Healthcare

https://www.viivhealthcare.com/what-we-do/dolutegravir-expanded-access-program.aspx

Dolutegravir Expanded Access Program. Dolutegravir is an integrase strand transfer inhibitor (INSTI), for use in combination with other anti-retroviral medicinal products for the treatment of HIV infected adults and adolescents above 12 years of age, approved by the Food and Drug Administration in August 2013 and by the European Medicines Agency in January 2014. Who can participate in the dolutegravir EAP (ING114916) or NPP (ING115502)? Have documented raltegravir or elvitegravir resistance. Have any con...

viivhealthcare.com

Media | ViiV Healthcare

https://www.viivhealthcare.com/media.aspx

These press releases are intended for business journalists and analysts/investors. ViiV Healthcare launches phase III programme evaluating a two-drug regimen combining dolutegravir and lamivudine for HIV-1 treatment. ViiV Healthcare launches phase III programme evaluating a two-drug regimen combining dolutegravir and lamivudine for HIV-1 treatment. ARIA study shows superior efficacy of Triumeq for treatment-naïve women living with HIV. ViiV Healthcare announces public tender agreement with Botswana Minis...

viivhealthcare.com

Home | ViiV Healthcare

https://www.viivhealthcare.com/??a=39

ViiV Healthcare launches phase III programme evaluating a two-drug regimen combining dolutegravir and lamivudine for HIV-1 treatment. MEDIA ALERT: ARIA shows superior efficacy of Triumeq for women. ViiV Healthcare presents 48-week data for the phase IIIb ARIA study in treatment-naive women at IAC 2016. Positive Action for Children Collaborathon Grants Announced. Learn more about the four new grants awarded from the first-ever Collaborathon held around the 21st International AIDS Conference.

viivhealthcare.com

Healthcare professionals | ViiV Healthcare

https://www.viivhealthcare.com/healthcare-professionals.aspx

ViiV Healthcare builds partnerships with healthcare professionals (HCPs) by offering expertise and the opportunity to work together on developing new treatments combining it with HCPs scientific and medical insights into patient care. We believe this partnership is fundamental to the progress of medical science and helps meet the needs of patients living with HIV. ViiV Healthcare Clinical Study Register. Dolutegravir Expanded Access Program. US Patient Assistance Programmes.

viivhealthcare.com

Community Partnerships | ViiV Healthcare

https://www.viivhealthcare.com/community-partnerships.aspx

The ViiV Healthcare Effect. Learn about our partners’ projects around the world, currently funded by our Positive Action, Positive Action Southern Initiative, Positive Action for Children Fund and Paediatric Innovation Seed Fund programmes. Positive Action Community Challenge. ViiV Healthcare is announcing its first challenge in the area of HIV and global health, focused on expanding access to health care in rural and other limited resource settings. Positive Action for Adolescents. Addressing gaps in se...